Key result
Contrast-enhanced CMR identified residual LAA perfusion in 4 of 7 patients, demonstrating a 9-fold higher signal-peak in the LAA apex compared to those without a leak.
Why the study?
Does contrast-enhanced CMR identify incorrect placement and persistent leaks in patients after transcatheter occlusion of the left atrial appendage?
Observational (n=7)
Single-blind
No
Does contrast-enhanced CMR identify incorrect placement and persistent leaks in patients after transcatheter occlusion of the left atrial appendage?
Contrast-enhanced CMR is a feasible, non-invasive imaging modality for evaluating device placement and detecting residual leaks after transcatheter left atrial appendage occlusion.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for contrast-enhanced CMR in post-LAAO leak detection; prospective validation needed before clinical adoption.
BACKGROUND: To evaluate the feasibility and value of first-pass contrast-enhanced dynamic and post-contrast 3D CMR in patients after transcatheter occlusion of left atrial appendage (LAA) to identify incorrect placement and persistent leaks. METHODS: 7 patients with different occluder systems (n = 4 PLAATO; n = 2 Watchman; n = 1 ACP) underwent 2 contrast-enhanced (Gd-DOTA) CMR sequences (2D TrueFISP first-pass perfusion and 3D-TurboFLASH) to assess localization, artifact size and potential leaks of the devices. Perfusion CMR was analyzed visually and semi-quantitatively to identify potential leaks. RESULTS: All occluders were positioned within the LAA. The ACP occluder presented the most extensive artifact size. Visual assessment revealed a residual perfusion of the LAA apex in 4 cases using first-pass perfusion and 3D-TurboFLASH indicating a suboptimal LAA occlusion.By assessing signal-to-time-curves the cases with a visually detected leak showed a 9-fold higher signal-peak in the LAA apex (567 ± 120% increase from baseline signal) than those without a leak (61 ± 22%; p < 0.03). In contrast, the signal increase in LAA proximal to the occluder showed no difference (leak 481 ± 201% vs. no leak 478 ± 125%; p = 0.48). CONCLUSION: This CMR pilot study provides valuable non-invasive information in patients after transcatheter occlusion of the LAA to identify correct placement and potential leaks. We recommend incorporating CMR in future clinical studies to evaluate new device types.
No takes yet. Share an insight, caveat, or question.
Mohrs et al. (2011) conducted an observational in Non-rheumatic atrial fibrillation with transcatheter occlusion of left atrial appendage (n=7). Contrast-enhanced CMR was evaluated on Signal-peak increase from baseline in the LAA apex (visually detected leak vs no leak) (p=<0.03). Contrast-enhanced CMR identified residual LAA perfusion in 4 of 7 patients, demonstrating a 9-fold higher signal-peak in the LAA apex compared to those without a leak.
Synapse has enriched 10 related papers. Consider them for comparative context: